论文部分内容阅读
目的分析基层医院急诊静脉溶栓治疗急性ST段抬高性心肌梗死(STEMI)的疗效和临床意义。方法对2009年1月～2010年12月,我院急诊科收治的ST段抬高性心肌梗死符合且用尿激酶溶栓治疗的78例患者的溶栓效果及并发症的相关内容进行回顾性分析。结果 78例急性ST段抬高性心梗患者血管再通率达70.51%(55/78),且溶栓治疗时间窗越早,患者血管再通率越高;而溶栓治疗不良事件以心律失常和出血较为常见。结论在没有条件开展介入治疗的基层医院,溶栓治疗是急性ST段抬高性心肌梗死安全有效的治疗方法;溶栓时间越早,血管再通率越高,治疗效果越好;值得在基层医院应用。
Objective To analyze the curative effect and clinical significance of emergency intravenous thrombolysis in primary hospital for acute ST-segment elevation myocardial infarction (STEMI). Methods From January 2009 to December 2010, 78 cases of ST-segment elevation myocardial infarction (STEMI) treated with Urokinase thrombolysis in our emergency department were retrospectively analyzed. analysis. Results The vascular recanalization rate was 70.51% (55/78) in 78 patients with acute ST-segment elevation myocardial infarction, and the earlier the thrombolysis time was, the higher the rate of recanalization was. However, the thrombolysis adverse events were arrhythmia and Bleeding is more common. Conclusions Thrombolytic therapy is a safe and effective treatment for ST-segment elevation myocardial infarction in primary hospitals without interventional conditions. The earlier the thrombolysis time and the higher the recanalization rate, the better the treatment is. Hospital application.